Skip to content
Loading your account…

MCK MCKESSON CORP

NYSEHealth careWholesale-Drugs, Proprietaries & Druggists' SundriesIrving, TXFY ends March 31

Profitable 5/5: Fiscal years with net income above zero, out of the last five reported.FY2026 10-K filed May 8, 2026 (SEC EDGAR)

FY2026 at a glance

Fundamentals from SEC filings, not quotes
Revenue
$403BYoYup 12.36%ended Mar 31, 2026
Net income
$4.76B1.2% margin
Diluted EPS
$38.38YoYup 49.22%
Free cash flow
$5.72B1.4% margin
Cash
$3.98BNet debt $2.55B
Total debt
$6.53B
About MCKESSON CORP

Overview

MCKESSON CORP (MCK) is listed on NYSE; the SEC classifies it under "Wholesale-Drugs, Proprietaries & Druggists' Sundries".

For fiscal 2026 (ended Mar 31, 2026) it reported revenue of $403.43B, up 12.4% from fiscal 2025.

Net income was $4.76B, a net margin of 1.2%.

At fiscal year end it had total assets of $82.32B and stockholders' equity of -$2.17B (-2.6% of assets).

Fiscal years shown
FY2017–FY2026 (10 years)
Latest 10-K
May 8, 2026
Latest filing
8-KOct 6, 2026
FY2017–FY2026 · annual 10-K

Charts

Revenue and net income

Revenue and net income, fiscal years FY2017 to FY2026.
PeriodRevenueNet incomeNet margin
FY2017$199B$5.07B2.6%
FY2018$208B$67M0.0%
FY2019$214B$34M0.0%
FY2020$231B$900M0.4%
FY2021$238B-$4.54B-1.9%
FY2022$264B$1.11B0.4%
FY2023$277B$3.56B1.3%
FY2024$309B$3B1.0%
FY2025$359B$3.3B0.9%
FY2026$403B$4.76B1.2%

Gross, operating and net margin

Gross, operating and net margin, fiscal years FY2017 to FY2026.
PeriodGross marginOperating marginNet margin
FY20175.7%3.6%2.6%
FY20185.4%0.4%0.0%
FY20195.5%0.4%0.0%
FY20205.2%1.1%0.4%
FY20215.1%-2.1%-1.9%
FY20225.0%0.8%0.4%
FY20234.5%1.6%1.3%
FY20244.2%1.3%1.0%
FY20253.7%1.2%0.9%
FY20263.6%1.5%1.2%

Diluted EPS

Diluted EPS, fiscal years FY2017 to FY2026.
PeriodEPS (diluted)
FY2017$22.73
FY2018$0.32
FY2019$0.17
FY2020$4.95
FY2021-$28.26
FY2022$7.23
FY2023$25.03
FY2024$22.39
FY2025$25.72
FY2026$38.38

Free cash flow vs net income

Free cash flow vs net income, fiscal years FY2017 to FY2026.
PeriodFree cash flowNet income
FY2017$4.34B$5.07B
FY2018$3.94B$67M
FY2019$3.61B$34M
FY2020$4.01B$900M
FY2021$4.09B-$4.54B
FY2022$4.05B$1.11B
FY2023$4.77B$3.56B
FY2024$3.88B$3B
FY2025$5.55B$3.3B
FY2026$5.72B$4.76B

Diluted shares

Diluted shares, fiscal years FY2017 to FY2026.
PeriodDiluted shares (weighted)
FY2017223M
FY2018209M
FY2019197M
FY2020182M
FY2021161M
FY2022154M
FY2023142M
FY2024134M
FY2025128M
FY2026124M

Cash vs total debt

Cash vs total debt, fiscal years FY2017 to FY2026.
PeriodCash & equivalentsTotal debt
FY2017$2.78B$8.55B
FY2018$2.67B$7.88B
FY2019$2.98B$7.6B
FY2020$4.02B$7.39B
FY2021$6.28B$7.15B
FY2022$3.53B$5.88B
FY2023$4.68B$5.59B
FY2024$4.58B$5.63B
FY2025$5.69B$5.65B
FY2026$3.98B$6.53B

Each bar is one fiscal year as reported in its 10-K; bars below the zero line are negative and gaps are years not reported. Per-share figures are as reported, not adjusted for stock splits; comparisons across a likely split are left blank.

FY2026 · 5-year trend

Ratios

Profitability

Gross margin
3.6%
Operating margin
1.5%
Net margin
1.2%
FCF margin
1.4%
Return on assets
6.0%

Growth

Growth. Compound annual growth: (end ÷ start)^(1 ÷ years) − 1, both ends positive.
Metric1y3y CAGR5y CAGR9y CAGR
Revenueup 12.36%up 13.39%up 11.11%—
EPS (diluted)up 49.22%up 15.31%—up 5.99%
Free cash flowup 3.08%up 6.24%up 6.93%up 3.11%
Change in share count
-3.12%

Financial strength

Current ratio
0.85×
Net debt
$2.55B
Interest coverage
25.1×
Equity / assets
-2.6%

Shareholder returns

Dividends per share
$3.17
Dividends paid
$381M
Buybacks
$4.75B
Payout ratio
8.0%
Stock comp. / revenue
0.1%
Piotroski F-Score · Altman Z''-Score

Quality screens

Piotroski F-Score

6 of 9 checks passed

FY2026 vs FY2025

  • PassPositive return on assets6.3%
  • PassPositive operating cash flow$6.16B
  • PassReturn on assets improved6.3% vs 4.9%
  • PassOperating cash flow above net income8.2% vs 6.3%
  • FailLong-term debt / assets fell6.4% vs 5.9%
  • FailCurrent ratio improved0.85× vs 0.9×
  • PassNo increase in share count124M vs 128M
  • FailGross margin improved3.6% vs 3.7%
  • PassAsset turnover improved5.37× vs 5.32×

Altman Z''-Score

Needs current assets and liabilities, retained earnings, operating income, total assets, liabilities and equity from the latest 10-K.

Screening heuristic, not a recommendation. Per-share figures are as reported, not adjusted for stock splits; comparisons across a likely split are left blank.

Last 10 fiscal years · newest first

Financial statements

USD millions, except per-share figures (USD). Share counts in millions.

Income statement

Income statement. USD millions, except per-share figures (USD). Share counts in millions.
MetricFY2026Mar 31, 2026FY2025Mar 31, 2025FY2024Mar 31, 2024FY2023Mar 31, 2023FY2022Mar 31, 2022FY2021Mar 31, 2021FY2020Mar 31, 2020FY2019Mar 31, 2019FY2018Mar 31, 2018FY2017Mar 31, 2017
Revenue403,430359,051308,951276,711263,966238,228231,051214,319208,357198,533
YoY (Revenue)+12.36%+16.22%+11.65%+4.83%+10.80%+3.11%+7.81%—+4.95%—
Gross profit14,55013,32312,82812,35813,13012,14812,02311,75411,18411,271
Research & development——————9671125341
Selling, general & admin.8,0968,5078,6577,77610,5378,8499,1688,4038,1387,466
Operating income6,2124,4223,9094,3812,038-5,0402,4898867627,109
Interest expense247265252248178217249———
Pretax income6,2014,3593,7894,6301,928-5,0341,1446102396,891
Income tax1,102878629905636-69518356-531,614
Net income4,7623,2953,0023,5601,114-4,53990034675,070
YoY (Net income)+44.52%+9.76%-15.67%+219.57%—-604.33%+2,547.06%-49.25%-98.68%—
EPS (basic)38.5525.8622.5425.237.32-28.264.980.170.3222.95
EPS (diluted)38.3825.7222.3925.037.23-28.264.950.170.3222.73
YoY (EPS (diluted))+49.22%+14.87%-10.55%+246.20%—-670.91%+2,811.76%-46.88%-98.59%—
Diluted shares (weighted)124128134142154161182197209223

Balance sheet

Balance sheet. USD millions, except per-share figures (USD). Share counts in millions.
MetricFY2026Mar 31, 2026FY2025Mar 31, 2025FY2024Mar 31, 2024FY2023Mar 31, 2023FY2022Mar 31, 2022FY2021Mar 31, 2021FY2020Mar 31, 2020FY2019Mar 31, 2019FY2018Mar 31, 2018FY2017Mar 31, 2017
Cash & equivalents3,9755,6914,5834,6783,5326,2784,0152,9812,6722,783
Inventory24,20723,00121,13919,69118,70219,24616,73416,70916,31015,278
Current assets57,21055,39847,97044,29246,23145,38242,22238,46537,13636,948
Goodwill11,31610,02210,1329,9479,4519,4939,3609,35810,92410,586
Total assets82,32375,14067,44362,32063,29865,01561,24759,67260,38160,969
Current liabilities67,01761,60452,35747,95748,46644,10342,62437,62636,68535,612
Short-term debt1,2671,191509687997421,0523301,1291,240
Long-term debt5,2594,4635,5794,6265,0806,4066,3357,2656,7517,305
Retained earnings22,29117,92114,97812,2959,0308,20213,02212,40912,98613,189
Stockholders' equity-2,172-2,074-1,971-1,857-2,272-215,0928,0949,80411,095
Shares outstanding120125130136145158162190202211

Cash flow

Cash flow. USD millions, except per-share figures (USD). Share counts in millions.
MetricFY2026Mar 31, 2026FY2025Mar 31, 2025FY2024Mar 31, 2024FY2023Mar 31, 2023FY2022Mar 31, 2022FY2021Mar 31, 2021FY2020Mar 31, 2020FY2019Mar 31, 2019FY2018Mar 31, 2018FY2017Mar 31, 2017
Operating cash flow6,1556,0854,3145,1594,4344,5424,3744,0364,3454,744
Capital expenditures436537431390388451362426405404
Free cash flow5,7195,5483,8834,7694,0464,0914,0123,6103,9404,340
YoY (Free cash flow)+3.08%+42.88%-18.58%+17.87%-1.10%+1.97%+11.14%-8.38%-9.22%—
Depreciation & amortization287272279272312344922949951910
Stock-based compensation2472261821621611511199569115
Share repurchases4,7503,1463,0253,6383,5167701,9541,6391,7092,311
Dividends paid381345314292277276294292262253
Dividends per share3.172.752.402.091.831.671.621.511.301.12
Key financials (annual, 10-K)

Values as reported in each fiscal year's Form 10-K (XBRL data on SEC EDGAR); growth and ratios are computed from those values. Revenue is the total revenue figure the company tagged (omitted when the only figure tagged is evidently partial, e.g. below net income); growth is only shown between consecutive ~12-month fiscal years reported with the same revenue measure. Per-share figures and share counts are as reported and not adjusted for later stock splits. — = not reported.

FY2026 · per diluted weighted share

Per share and valuation context

EPS (diluted)
$38.38
Revenue per share
$3,250.85
FCF per share
$46.08
Book value per share
-$17.50
Tangible book per share
-$108.69
Cash per share
$32.03
Dividends per share
$3.17
Public floatas of Sep 30, 2025
$95.3B

Price ratios need a live quote. This page shows no stock prices. Per-share figures are as reported, not adjusted for stock splits; comparisons across a likely split are left blank.

Price ratio calculator

Type a share price to compute ratios from the latest 10-K figures. Nothing is stored or sent. (FY2026)

Market capPrice × diluted weighted shares
—
P/EPrice ÷ diluted EPS
—
P/BPrice ÷ book value per share
—
P/SPrice ÷ revenue per share
—
P/FCFPrice ÷ FCF per share
—
Dividend yieldDividends per share ÷ price
—
SEC EDGAR

Filing timeline

  1. 8-K
    Current report· Oct 6, 2026(SEC EDGAR)
    • 7.01Regulation FD disclosure
    • 9.01Financial statements and exhibits
  2. 8-K
    Current report· Aug 25, 2026(SEC EDGAR)
    • 7.01Regulation FD disclosure
    • 9.01Financial statements and exhibits
  3. 10-Q
    Quarterly report· Jun 30, 2026(SEC EDGAR)
  4. 8-K
    Current report· Aug 5, 2026(SEC EDGAR)
    • 2.02Results of operations
    • 9.01Financial statements and exhibits
  5. 8-K
    Current report· Jul 22, 2026(SEC EDGAR)
    • 5.07Shareholder vote results
  6. 8-K
    Current report· Jun 29, 2026(SEC EDGAR)
    • 5.02Officer or director changes
    • 7.01Regulation FD disclosure
    • 9.01Financial statements and exhibits
  7. DEF 14A
    Proxy statement· Mar 31, 2026(SEC EDGAR)
  8. 8-K
    Current report· Jun 9, 2026(SEC EDGAR)
    • 1.01Material agreement
    • 2.03New financial obligation
    • 9.01Financial statements and exhibits
  9. 10-K
    Annual report· Mar 31, 2026(SEC EDGAR)
  10. 8-K
    Current report· May 7, 2026(SEC EDGAR)
    • 2.02Results of operations
    • 9.01Financial statements and exhibits
All filings on SEC EDGAR

Frequently asked questions

What does MCKESSON CORP do?

The SEC classifies MCKESSON CORP under Standard Industrial Classification (SIC) code 5122, "Wholesale-Drugs, Proprietaries & Druggists' Sundries". It is headquartered in Irving, TX. It is incorporated in DE. In fiscal 2026 it reported revenue of $403.43B and net income of $4.76B in its annual 10-K report.

What was MCKESSON CORP's revenue in 2026?

MCKESSON CORP reported revenue of $403.43B for fiscal 2026, which ended Mar 31, 2026, up 12.4% from $359.05B in fiscal 2025, according to its annual 10-K report filed with the SEC on May 8, 2026.

What was MCKESSON CORP's net income in 2026?

MCKESSON CORP reported net income of $4.76B for fiscal 2026, a net margin of 1.2% of revenue.

Where is MCKESSON CORP listed?

According to the SEC, MCKESSON CORP's ticker MCK is listed on NYSE.

When does MCKESSON CORP's fiscal year end?

According to the SEC, MCKESSON CORP's fiscal year ends on March 31; its latest reported fiscal year (2026) ended Mar 31, 2026.

Source: SEC EDGAR · Last updated:

Ver en español

Not investment advice: This page shows financial data that companies reported to the US Securities and Exchange Commission, for information only. It is not investment advice or a recommendation to buy or sell any security, and it shows no stock prices. Data may be incomplete, restated or out of date — check the original filings on SEC EDGAR before making decisions.